Dongkook Pharmaceutical Co., Ltd.

Founded in 1968, Dongkook Pharmaceutical has concentrated on R&D and technology innovation, becoming well known for high-brand-value OTC products in Korea, alongside developing and producing therapeutic products including anesthetics, contrast media and anti-cancer agents. The company is recognized by domestic and foreign authorities for the quality of its finished products, medical devices and APIs, and currently exports finished products, medical devices and APIs internationally.